IRS1 and type 2 diabetes mellitus: As the activation of the mammalian target of rapamycin (mTOR) and its downstream effectors, S6 kinase and insulin receptor substrate-1, the elevating BCAA may disrupt insulin signaling, thus triggering T2D [54,55].